158 related articles for article (PubMed ID: 24012740)
1. Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay.
Yarrow JF; Beck DT; Conover CF; Beggs LA; Goldberger BA; Borst SE
Steroids; 2013 Dec; 78(12-13):1220-5. PubMed ID: 24012740
[TBL] [Abstract][Full Text] [Related]
2. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
3. Derivatization with 2-hydrazino-1-methylpyridine enhances sensitivity of analysis of 5α-dihydrotestosterone in human plasma by liquid chromatography tandem mass spectrometry.
Faqehi AM; Denham SG; Naredo G; Cobice DF; Khan S; Simpson JP; Sabil G; Upreti R; Gibb F; Homer NZ; Andrew R
J Chromatogr A; 2021 Mar; 1640():461933. PubMed ID: 33588275
[TBL] [Abstract][Full Text] [Related]
4. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
5. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
6. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry.
Shiraishi S; Lee PW; Leung A; Goh VH; Swerdloff RS; Wang C
Clin Chem; 2008 Nov; 54(11):1855-63. PubMed ID: 18801940
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
9. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry.
Upreti R; Naredo G; Faqehi AM; Hughes KA; Stewart LH; Walker BR; Homer NZ; Andrew R
Talanta; 2015 Jan; 131():728-35. PubMed ID: 25281165
[TBL] [Abstract][Full Text] [Related]
11. Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5alpha-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism.
Licea-Perez H; Wang S; Szapacs ME; Yang E
Steroids; 2008 Jul; 73(6):601-10. PubMed ID: 18329061
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
[TBL] [Abstract][Full Text] [Related]
13. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
[TBL] [Abstract][Full Text] [Related]
14. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.
Rothman MS; Carlson NE; Xu M; Wang C; Swerdloff R; Lee P; Goh VH; Ridgway EC; Wierman ME
Steroids; 2011 Jan; 76(1-2):177-82. PubMed ID: 21070796
[TBL] [Abstract][Full Text] [Related]
15. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men.
Lakshman KM; Kaplan B; Travison TG; Basaria S; Knapp PE; Singh AB; LaValley MP; Mazer NA; Bhasin S
J Clin Endocrinol Metab; 2010 Aug; 95(8):3955-64. PubMed ID: 20534765
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
[TBL] [Abstract][Full Text] [Related]
17. Role of 5α-dihydrotestosterone in testicular development of gilthead seabream following finasteride administration.
García-García M; Sánchez-Hernández M; García-Hernández MP; García-Ayala A; Chaves-Pozo E
J Steroid Biochem Mol Biol; 2017 Nov; 174():48-55. PubMed ID: 28739284
[TBL] [Abstract][Full Text] [Related]
18. The Simultaneous measurement of serum testosterone and 5α-dihydrotestosterone by gas chromatography-mass spectrometry (GC-MS).
Kannenberg F; Fobker M; Schulte E; Pierściński G; Kelsch R; Zitzmann M; Nofer JR; Schüring AN
Clin Chim Acta; 2018 Jan; 476():15-24. PubMed ID: 29122541
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
Caserini M; Radicioni M; Leuratti C; Terragni E; Iorizzo M; Palmieri R
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):19-27. PubMed ID: 26636418
[TBL] [Abstract][Full Text] [Related]
20. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
Kinniburgh D; Anderson RA; Baird DT
J Androl; 2001; 22(1):88-95. PubMed ID: 11191092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
